![](https://curamirtherapeutics.com/wp-content/uploads/2020/06/iStock-477013712-300x200.jpg)
Delos Capital Announces the Launch of Curamir Therapeutics Inc.
HONG KONG, Sept. 20, 2019 /PRNewswire/ — Delos Capital today announces that it has launched Curamir Therapeutics Inc., a Woburn, MA-based biotechnology company pioneering micro RNA (miRNA) based